154 related articles for article (PubMed ID: 22583006)
1. Protective effect of polysaccharides on the stability of parenteral emulsions.
Chai G; Sun F; Shi J; Tian B; Tang X
Drug Dev Ind Pharm; 2013 May; 39(5):646-56. PubMed ID: 22583006
[TBL] [Abstract][Full Text] [Related]
2. Parenteral emulsions stabilized with a mixture of phospholipids and PEG-660-12-hydroxy-stearate: evaluation of accelerated and long-term stability.
Jumaa M; Müller BW
Eur J Pharm Biopharm; 2002 Sep; 54(2):207-12. PubMed ID: 12191693
[TBL] [Abstract][Full Text] [Related]
3. Parenteral microemulsions: an overview.
Date AA; Nagarsenker MS
Int J Pharm; 2008 May; 355(1-2):19-30. PubMed ID: 18295991
[TBL] [Abstract][Full Text] [Related]
4. Development of multiple W/O/W emulsions as dermal carrier system for oligonucleotides: effect of additives on emulsion stability.
Schmidts T; Dobler D; Schlupp P; Nissing C; Garn H; Runkel F
Int J Pharm; 2010 Oct; 398(1-2):107-13. PubMed ID: 20674722
[TBL] [Abstract][Full Text] [Related]
5. Formation of egg yolk-modified starch complex and its stabilization effect on high internal phase emulsions.
Xu L; Gu L; Su Y; Chang C; Dong S; Tang X; Yang Y; Li J
Carbohydr Polym; 2020 Nov; 247():116726. PubMed ID: 32829848
[TBL] [Abstract][Full Text] [Related]
6. Formulation and optimization of pH sensitive drug releasing O/W emulsions using Albizia lebbeck L. seed polysaccharide.
Varma CAK; Jayaram Kumar K
Int J Biol Macromol; 2018 Sep; 116():239-246. PubMed ID: 29719218
[TBL] [Abstract][Full Text] [Related]
7. A study of the stability of W/O/W multiple emulsions.
Yan N; Zhang M; Ni P
J Microencapsul; 1992; 9(2):143-51. PubMed ID: 1593397
[TBL] [Abstract][Full Text] [Related]
8. Influence of biopolymer emulsifier type on formation and stability of rice bran oil-in-water emulsions: whey protein, gum arabic, and modified starch.
Charoen R; Jangchud A; Jangchud K; Harnsilawat T; Naivikul O; McClements DJ
J Food Sci; 2011; 76(1):E165-72. PubMed ID: 21535669
[TBL] [Abstract][Full Text] [Related]
9. Proteins, polysaccharides, and their complexes used as stabilizers for emulsions: alternatives to synthetic surfactants in the pharmaceutical field?
Bouyer E; Mekhloufi G; Rosilio V; Grossiord JL; Agnely F
Int J Pharm; 2012 Oct; 436(1-2):359-78. PubMed ID: 22759644
[TBL] [Abstract][Full Text] [Related]
10. Efficiency of emulsifier-free emulsions and emulsions containing rapeseed lecithin as delivery systems for vectorization and release of coenzyme Q10: physico-chemical properties and in vitro evaluation.
Kaci M; Arab-Tehrany E; Dostert G; Desjardins I; Velot E; Desobry S
Colloids Surf B Biointerfaces; 2016 Nov; 147():142-150. PubMed ID: 27497933
[TBL] [Abstract][Full Text] [Related]
11. Influence of a lipophilic drug on the stability of emulsions: an important approach on the development of lipidic carriers.
Formiga FR; Fonseca IA; Souza KB; Silva AK; Macedo JP; Araújo IB; Soares LA; Egito ES
Int J Pharm; 2007 Nov; 344(1-2):158-60. PubMed ID: 17614224
[TBL] [Abstract][Full Text] [Related]
12. An investigation into the characteristics and drug release properties of multiple W/O/W emulsion systems containing low concentration of lipophilic polymeric emulsifier.
Vasiljevic D; Parojcic J; Primorac M; Vuleta G
Int J Pharm; 2006 Feb; 309(1-2):171-7. PubMed ID: 16406403
[TBL] [Abstract][Full Text] [Related]
13. Improvement of emulsifying properties of oat protein isolate-dextran conjugates by glycation.
Zhang B; Guo X; Zhu K; Peng W; Zhou H
Carbohydr Polym; 2015; 127():168-75. PubMed ID: 25965470
[TBL] [Abstract][Full Text] [Related]
14. Development and rheological properties of ecological emulsions formulated with a biosolvent and two microbial polysaccharides.
Trujillo-Cayado LA; Alfaro MC; Muñoz J; Raymundo A; Sousa I
Colloids Surf B Biointerfaces; 2016 May; 141():53-58. PubMed ID: 26826979
[TBL] [Abstract][Full Text] [Related]
15. Determination of amylose/particulate relationship in hydroxyethylstarch.
Stephens D; Bares D; Robinson D; Pec E
PDA J Pharm Sci Technol; 1999; 53(4):181-5. PubMed ID: 10754711
[TBL] [Abstract][Full Text] [Related]
16. Parenteral nanoemulsions as promising carriers for brain delivery of risperidone: Design, characterization and in vivo pharmacokinetic evaluation.
Đorđević SM; Cekić ND; Savić MM; Isailović TM; Ranđelović DV; Marković BD; Savić SR; Timić Stamenić T; Daniels R; Savić SD
Int J Pharm; 2015 Sep; 493(1-2):40-54. PubMed ID: 26209070
[TBL] [Abstract][Full Text] [Related]
17. Effects of emulsifier concentration, composition, and order of addition in squalene-phosphatidylcholine oil-in-water emulsions.
Fox CB; Lin S; Sivananthan SJ; Dutill TS; Forseth KT; Reed SG; Vedvick TS
Pharm Dev Technol; 2011 Oct; 16(5):511-9. PubMed ID: 20550484
[TBL] [Abstract][Full Text] [Related]
18. "Vitamin E" fortified parenteral lipid emulsions: Plackett-Burman screening of primary process and composition parameters.
Alayoubi A; Nazzal M; Sylvester PW; Nazzal S
Drug Dev Ind Pharm; 2013 Feb; 39(2):363-73. PubMed ID: 22554350
[TBL] [Abstract][Full Text] [Related]
19. Non-covalent interactions between proteins and polysaccharides.
McClements DJ
Biotechnol Adv; 2006; 24(6):621-5. PubMed ID: 16935458
[TBL] [Abstract][Full Text] [Related]
20. Dual asymmetric centrifugation as an alternative preparation method for parenteral fat emulsions in preformulation development.
Tenambergen F; Maruiama CH; Mäder K
Int J Pharm; 2013 Apr; 447(1-2):31-7. PubMed ID: 23454573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
